Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003168614 | SCV003867883 | likely pathogenic | Hereditary cancer-predisposing syndrome | 2023-02-01 | criteria provided, single submitter | clinical testing | The p.M1268T variant (also known as c.3803T>C), located in coding exon 18 of the MET gene, results from a T to C substitution at nucleotide position 3803. The methionine at codon 1268 is replaced by threonine, an amino acid with similar properties. This variant has been reported in individuals with papillary renal cell carcinoma (Lubensky IA et al. Am J Pathol, 1999 Aug;155:517-26) including a patient with bilateral disease (Ambry internal data). This variant has shown constitutive kinase activity in multiple functional studies and renders MET more sensitive to MET inhibitors (Jeffers M et al. Proc Natl Acad Sci U S A, 1997 Oct;94:11445-50; Bardelli A et al. Proc Natl Acad Sci U S A, 1998 Nov;95:14379-83; Medová M et al. Int J Cancer, 2012 Feb;130:728-34). Cells expressing M1268T showed its accumulation in intracellular vesicles at higher levels than wild type MET; this was associated with increasing tumorgenicity (Joffre C et al. Nat Cell Biol, 2011 Jun;13:827-37). Based on internal structural analysis, M1268T disrupts a key position in the kinase P+1 loop which plays a role in substrate recognition (Xu W et al. Nature, 1997 Feb;385:595-602; Schmidt L et al. Oncogene, 1999 Apr;18:2343-50; Miller M et al. Proteins, 2001 Jul;44:32-43; Yuan ZL et al. Mol Cell Biol, 2004 Nov;24:9390-400; Yuan H et al. Eur J Med Chem, 2018 Jan;143:491-502). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. |
| Database of Curated Mutations |
RCV000442904 | SCV000505128 | likely pathogenic | Carcinoma | 2016-05-13 | no assertion criteria provided | literature only | |
| Database of Curated Mutations |
RCV000425451 | SCV000505129 | likely pathogenic | Renal carcinoma | 2015-07-14 | no assertion criteria provided | literature only |